Phosphatidylethanol (PEth) is a direct nonoxidative metabolite of ethanol that may be measured in clinical samples as a marker for monitoring alcohol consumption. It has been used in a wide variety of clinical and nonclinical settings; however, its investigation in relation to liver disease has been limited. This study aims at providing a short review on the applications and challenges for the incorporation of PEth testing in identifying alcohol intake in this patient population.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: